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Abstract 
Background: Coronavirus Disease 2019 is affecting most countries around the world, including Poland. In response, 
all elective surgeries have been postponed. We asked patients and surgeons when they want bariatric surgery to 
resume after pandemic. The main aim of the study was to determine patients’ and surgeons’ expectations about when 
to resume bariatric surgery regarding COVID‑19 pandemic state.
Methods: The study was conducted in two groups: Group 1—bariatric patients; Group 2—bariatric surgeons. Two 
online surveys were distributed.
Results: A total of 895 patients, 299 before, 596 after surgery and 32 surgeons took part in survey. All patients and 
surgeons declared willingness to resume bariatric surgeries after pandemic and responded that they should be 
resumed immediately the World Health Organization announces end of pandemic (42%). The majority of patients 
before surgery answered that bariatric procedures should be resumed immediately the number of daily incidents 
begins to decrease (53%). In the patient group, current body mass index (p < 0.001) and contact with COVID+/quar‑
antined persons (p < 0.001) had impact on the response to resumption of bariatric procedures.
Conclusions: Patients opted to wait for bariatric surgery until the oncological queue has become shorter. Surgeons 
presented a readiness to resume both procedures in parallel.
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Background
The COVID-19 is affecting most countries around the 
world, including Poland [1]. The coronavirus pandemic 
has had a radical impact on the functioning of healthcare 
systems worldwide. The health crisis has also brought 
new challenges to surgical care, including bariatric sur-
gery. In response to the COVID-19 pandemic, a strategy 
of postponing elective surgery has been adopted by most 
surgical societies [2, 3]. Bariatric surgery is one of the 
first disciplines that has largely implemented this strat-
egy. According to The International Federation for the 
Surgery of Obesity and Metabolic Disorders (IFSO) rec-
ommendations, all elective surgical and endoscopic cases 
for metabolic and bariatric surgery should be postponed 
in the interim. Furthermore, clinic and hospital visits are 
not recommended [4], as other surgical and non-urgent 
oncological procedures have also been recommended to 
be cancelled. However, promises to resume procedures 
at the earliest available date once the pandemic subsides 
have been offered by the healthcare authorities. The 
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extended waiting lists at surgeries will be another impor-
tant issue after the pandemic.
The number of bariatric procedures performed before 
the pandemic was insufficient in relation to the rising 
prevalence of obesity and the needs of bariatric patients 
worldwide [5, 6]. In addition, the waiting list for bariatric 
procedures is growing rapidly as a result of the pandemic. 
The increasing negative effects of a pandemic outbreak 
affect bariatric surgeons, surgical centers, patients and 
health care systems. Current efforts are mainly focused 
on reorganizing the functioning of hospitals and wards to 
defeat the coronavirus. There is a lack of data on plans for 
post-pandemic bariatric care organizations.
To effectively prepare bariatric teams, bariatric care 
organizations should implement their strategies immedi-
ately after the pandemic has ended. An appropriate tim-
ing for the resumption of bariatric procedures should be 
determined first.
Methods
The aim of the study was to define an appropriate time 
to resume bariatric surgery after the end of the SARS-
COV-2 pandemic.
Study design
The study was conducted between 8 and 22 April 2020 
in two groups: Group 1—bariatric patients, Group 2—
bariatric surgeons. Two anonymous online surveys were 
designed. Surgeons from four bariatric centers were 
responsible for distribution of survey and gathering of 
material. The first survey was prepared for patients from 
the Polish Association of Bariatric Patients (CHLO) and 
distributed online among patients. The data collected in 
the patient survey were also analysed on the impact of 
the pandemic on long-term effects of bariatric treatment 
[7]. The second survey was sent to all bariatric surgeons 
associated with the Metabolic and Bariatric Chapter at 
the Association of Polish Surgeons (SCMiB) who were 
invited to take part in the study by recruiting surgeons 
via e-mail through the SCMiB mailing list. In order to 
disseminate the survey to surgeons and encourage as 
many participants as possible, the survey also appeared 
on the society’s official website. The invitation to the pro-
ject and the introduction to the questionnaire give details 
of the study design, assumptions of the study and types 
of questions. The survey included precise guidelines on 
how to be fulfilled. Participation in both surveys was vol-
untary. Participants were required to give their consent 
to participate in the study as their response to the first 
survey question, which also supplied information on how 
to withdraw consent.
Inclusion and exclusion criteria
Group 1 included patients who were members of CHLO 
and who answered all the questions in the survey. The 
group contained patients before and after surgery. Can-
cer patients or patients with complications after bariat-
ric interventions whose surgery could not be postponed 
were advised not to complete the questionnaire. Group 
2 included surgeons and general surgery residents who 
are members of SCMiB working in bariatric centers. All 
eager participants in the association, regardless of cer-
tification, were included in the study. However, inactive 
surgeons (due to retirement, sick leave, vacation, or other 
reason for being out of practice during the pandemic) 
were excluded.
Survey
Questionnaires for both study groups were accessible 
online. There was no time limitation on completion. Both 
surveys were divided into two parts.
The first part consisted of questions covering consent 
to participate and basic demographic data character-
izing the groups of patients and surgeons. The group of 
patients was asked to state their age, sex, current body 
mass index (BMI), obesity comorbidites, whether they 
had undergone bariatric procedures in the past, contact 
with COVID+/quarantined persons and COVID status 
of the hospital taking care of them. Questions to the sur-
geon group concerned age, sex, stage of surgical training, 
type of employing hospital, COVID status of employing 
hospital and number of bariatric procedures performed 
in 2019 and 2020 until the start of the pandemic.
The second part included the same questions in both 
surveys. A group of patients and a group of surgeons 
were first asked their opinion on when bariatric surgery 
should be reinstated. In view of the lengthening waiting 
list for other elective procedures, especially oncological 
operations, both surveys then asked for the respondent’s 
opinion on how to reconcile the waiting lists for bariatric 
procedures with those for other elective surgery, includ-
ing oncological procedures (Fig. 1).
Statistical analysis
Results were presented as mean plus standard deviation 
or median with interquartile range. To assess factors that 
could potentially influence the responses provided, uni-
variate and multivariate regression models were run on 
Statistica 13.5 PL (Statsoft, USA).
Results
A total of 927 participants took part in the survey (895 
patients/32 surgeons). The study group included 792 
(85%) females and 135 (15%) males. The median age 
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Second part of both questionnaires
What is Your opinion on when to resume bariatric operations?
Only after the introduction of SARS-CoV-2 vaccination.
Immediately when the number of daily incidents in the country begins to decrease.
Only after the last patient with COVID-19 will be discharded from the hospital.
Immediately when WHO announces the end of a pandemic.
No opinion.
What is Your opinion on when to resume bariatric procedures in relation to oncological surgery?
Only when the queue for oncological procedures will be shortened.
At the same time as oncological procedures.
Due to the low risk of complications in bariatrics, it can be resumed before oncological procedures.
No opinion.
First part of questionnaires
Patients survey Surgeons survey
Please enter Your age: Please enter Your age:
Please select Your sex: F/M Please select Your sex: F/M
Please enter Your current BMI: Please choose Your stage of surgical training: 
specialist surgeons 
residents














What is Your stage of bariatric treatment?
I am before bariatric procedure. 
I have undergone bariatric procedure.








Please enter the numbers of bariatric procedures 
performed in 2019:




Please enter the numbers of bariatric procedures 
performed in 2020 until pandemic:
Fig. 1 Questionsasked in surveys—patients and surgeons group
Page 4 of 8Dudek et al. BMC Surg          (2021) 21:131 
was 39 (33–45). Respondents were associated with both 
COVID-dedicated hospitals (22%) and non-COVID-ded-
icated hospitals (77%).
Group 1 characteristics (patients)
The median age of the patient group was 39 (33–45). 
The study group included 786 females (88%) and 109 
males (12%). The median current BMI was 34.77 (29.3–
41.18). 74% of patients presented with obesity comor-
bidities. The patients who participated in the study were 
from both COVID-dedicated hospitals (198; 22.1%) and 
non-COVID-dedicated hospitals (697; 77.9%). 56 of the 
patients (6.26%) had had contact with COVID+ or a per-
son who was quarantined. The patient study group was 
divided into two subgroups: patients before surgery and 
patients and after surgery (299/596). Basic characteristics 
of both subgroups are presented in Table 1.
Group 2 characteristics (surgeons)
The mean age of surgeons who participated the survey 
was 42 ± 10. The group contained 26 males (81%) and 
6 females (19%). The group contained 26 specialist sur-
geons (81%) and 6 residents (19%). 53% of the respond-
ents were employed in university hospitals, 38% of them 
in district hospitals and 9% in state departments. 12 
surgeons were working in the COVID-dedicated hospi-
tals (38%), while 20 in non-COVID-dedicated hospitals 
(63%). Median number of bariatric surgeries provided 
altogether in the hospital in 2019 was 150 (82–200). 
Median number of bariatric surgeries performed overall 
in 2020 until the start of the pandemic was 29 (20–50) 
(Table 2).
When bariatric procedures should be resumed
All patients and surgeons declared a high willingness 
to resume bariatric surgery after the SARS-CoV-2 pan-
demic, with a median score of 10 (10–10). There was no 
statistically significant difference between patients and 
surgeons in their answers to questions on the timing for 
resuming bariatric procedures. A majority in both groups 
supported the position that bariatric surgery should 
be resumed as soon as the World Health Organization 
(WHO) declares an end to the pandemic: 377 (42.4%), 14 
(43.8%). The distribution of the remaining answers was as 
follows: immediately the number of daily incidents in the 
country begins to decrease: 251 (28.1%), 7 (21.9%); only 
after the last patient with COVID-19 has been discharged 
from hospital: 121 (13.5%), 9 (28.1%); only after the intro-
duction of SARS- CoV-2 vaccinations: 95 (10.6%), 1 
(3.1%); no opinion: 51 (5.4%), 1 (3.1%) (Fig. 2).
Answers given by the two subgroups of patients (before 
and after surgery) presented two statistically-significant 
different approaches to the question asked. The majority 
Table 1 Basic characteristics of group 1
All patients Patients before surgery Patients after surgery
n (%) 895 (100%) 299 (33%) 596 (67%)
Median age, years (IQR) 39 (33–45) 38 (32–44) 39 (33–45)
Males/Females, n (%) 109/786 (12%/88%) 39/260 (13%/87%) 69/527 (12%/88%)
Median BMI, kg/m2 (IQR) 34.77 (29.3–41.18) 42.61 (38.99–47.63) 31.21 (27.54–47.63)
Obesity comorbidities, n (%) 661 (74%) 239 (80%) 422 (71%)
Contact with COVID+/quarantined person 56 (6.26%) 10 (3.34%) 46 (7.72%)
Hospital of patient care
 COVID‑dedicated hospital 198 (22.12%) 79 (26.42%) 119 (19.97%)
 Non‑COVID dedicated hospital 697 (77.88%) 220 (73.58%) 477 (80.03%)
Table 2 Basic characteristics of group 2
Bariatric surgeons
n (%) 32 (100%)
Mean age, years ± SD 42 ± 10
Males/females, n (%) 26/6 (81%/19%)
Stage of surgical training
 Specialist surgeons, n (%) 26 (81%)
 Residents, n (%) 6 (19%)
Type of employing hospital
 University hospital, n (%) 17 (53%)
 State department, n (%) 3 (9%)
 District hospital/city hospital, n (%) 12 (38%)
COVID status
 COVID‑dedicated hospital 12 (37.5%)
 Non‑COVID dedicated hospital 20 (62.5%)
Numbers of bariatric procedures
 Median number of bariatric procedures in 2019, n 
(IQR)
150 (82–200)
 Median number of bariatric procedures in 2020 
until pandemic, n (IQR)
29 (20–50)
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of patients in the before surgery subgroup answered that 
bariatric procedures should be resumed immediately 
the number of daily incidents in the country begins to 
decrease: 157 (52.5%), while the most popular answer 
in the after surgery subgroup was immediately WHO 
announces the end of the pandemic: 291 (48.8%).
Being associated with a COVID-dedicated hospital 
might have had an impact on the opinions of both groups 
on restoring bariatric surgery: after WHO announces 
the end of the pandemic (p = 0.02) and only after the last 
patient with COVID-19 has been discharged (p < 0.001).
Among the patient group, current BMI (p < 0.001) 
and contact with a COVID+/quarantined person 
(p < 0.001) influenced opinions on resumption of bariat-
ric procedures after daily incidents in the country start to 
decrease. Answering that resumption should take place 
immediately WHO announces the end of the pandemic 
might be related to the status of surgery for that patient 
(p < 0.001). The statistical analysis indicated that factors 
like stage of surgical training, type of employing hospital, 
COVID status of employing hospital and number of bari-
atric procedures in 2019 or in 2020 until the start of the 
pandemic did not influenced the opinions given by sur-
geons (p > 0.050).
Resumption of bariatric procedures in relation 
to oncological surgery
The answers of the patient and surgeon groups to the 
question when bariatric procedures should be resumed 
in relation to oncological surgery differed significantly. 
The majority of patients opted for resumption of bari-
atric procedures only after managing the oncological 
queue: 396 (46%). However, most surgeons stated that 
bariatric procedures should be resumed in parallel with 
oncological procedures: 15 (48.4%). Analyzing the two 
subgroups, both in patients before and after surgery, the 
majority pointed out that shortening the queue for onco-
logical procedures should be the priority: 90 (30.1%), 306 
(54.5%). However, there was a significant difference in 
opinions on the parallel resumption of oncological and 
bariatric procedures between patients before and after 
surgery: (74 (25%) vs. 67 (11.4%) p < 0.001) (Fig. 3).
Discussion
The study presented here is the result of a national sur-
vey, the aim of which was to begin discussion with both 
surgeons and patients on the most appropriate time to 
resume bariatric surgery. The study showed a high will-
ingness by all participants to resume bariatric surgery 
immediately after the SARS-CoV-2 pandemic ends. The 
survey affirmed high patient expectations for bariatric 
operations to be resumed as soon as WHO announces 
the end of the pandemic.
The value of the study is to highlight patients’ perspec-
tives on the timing of resumption of bariatric surgery 
suspended due to the prevailing SARS-CoV-2 pandemic, 
as well as patients’ readiness for surgery, which could be 
affected by decreased motivation, difficult preparation 
Fig. 2 Time when bariatric procedures should be resumed
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for surgery, or concerns about hospitalization in the era 
of the pandemic.
To broadly analyze the impact of the pandemic on 
bariatric care in Poland, we conducted a survey with 
bariatric surgery specialists, who, through a survey, 
were asked about the feasibility of bariatric care during 
the pandemic, their bariatric center status (COVID/non 
COVID), and asked their views on the impact of the pan-
demic on the future of bariatric care [8]. The results of 
the study led to the conclusion that bariatric surgery spe-
cialists are ready to resume surgery as soon as the pan-
demic subsides and that they do not believe the pandemic 
will affect the safety of bariatric surgery. The results 
prompted us to consider bariatric patients’ views com-
pared to specialists on when to resume bariatric surgery 
and to discuss issues that may influence their decisions.
According to the latest data, obesity may present 
a higher risk for severe illness from COVID-19 and it 
can significantly worsen the prognosis of pneumonia 
[9, 10]. Sockalingam et  al. point out the tremendous 
psychological impact of the pandemic; an increase in 
eating psychopathology and binge eating syndrome 
can have a strong negative effect on obesity manage-
ment and gaining weight [11]. The group of patients 
who experienced delays in the preoperative period 
showed a greater desire to resume surgery as soon as 
the pandemic curve flattens compared to patients after 
surgery. The dominant opinion among patients who 
had completed their treatment was to wait until WHO 
announces the end of the pandemic. Current BMI and 
contact with a COVID+/quarantined person should 
be taken into consideration as the most likely factors 
to influence patient opinions. Those findings may be 
related to patients who fear that they are in the high-
risk group feeling a desperate need for surgery. On the 
other hand, many scientists are warning of the likeli-
hood of a second wave of the epidemic in the fall [12]. 
The prospect of a rebound of the epidemic may also be 
increasing patients’ desperation for surgery. The sur-
geon group showed a high readiness to provide bariat-
ric surgery treatment as soon as possible after the end 
of the pandemic. The COVID status of the employing 
hospital does not seem to have had an influence on the 
answers given.
The effect of bariatric treatments is not only weight 
loss, but also a reduction in the number of coexisting dis-
eases, and further improving the quality of life. A good 
example of how important bariatric treatments play a role 
in improving the quality of life is the problem of Obstruc-
tive Sleep Apnea (OSA). Bariatric surgeries reduce the 
symptoms of OSA and improve sleep quality and daytime 
sleepiness [13]. Lack of possibility of surgical treatment 
results in shortened quality adjusted life years.
What is more, the lack of an appropriate quality of 
sleep lowers immunity, which may additionally cause 
patients’ anxiety associated with pandemic situation and, 
Fig. 3 Resumption of bariatric procedures in relation to oncological surgery
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on the other hand, may increase their desire to take up 
surgical treatment quickly [14].
Another challenge in the case of restoring bariat-
ric procedures will be the need to observe whether the 
SARS-CoV-2 infection affects the longterm effects of sur-
gical treatment. Similar studies have so far been designed 
for other types of infections [15].
In the context of oncological treatment, patients opted 
to wait for bariatric surgery until the oncological queue is 
shorter. However, surgeons showed a readiness to resume 
both procedures in parallel. A prioritization strategy 
should be established that is appropriate to the readiness 
of surgeons and the needs of patients.
This study is associated with several limitations. Firstly, 
possible limitations of our study include recall bias and 
the subjectivity of patients and surgeons in stating their 
opinions. Secondly, free text comments provided by par-
ticipants were not collected in the survey. It might be 
worthwhile extending the study to include a qualitative 
analysis. Additionally, the survey was limited to patients 
who are members of the Polish Association of Bariatric 
Patients (CHLO) and may not reflect the entire bariatric 
population; however, it is worth noting that CHLO mem-
bers include a significant proportion of bariatric patients 
from all over the country. The second survey was dedi-
cated only to bariatric surgeons. The group of surgeons 
specializing in bariatrics in Poland is limited. Asking for 
the opinion of all surgeons could be valuable. As a final 
point, it should be noted that we concentrated only on 
Polish bariatric departments and Polish patients so it may 
be difficult to extrapolate our results to other countries; 
however, we anticipate that most bariatric surgeons and 
patients have similar problems.
Conclusions
A timing for the resumption of bariatric procedures 
should be established in line with the needs of patients 
and the readiness of surgeons. The overall opinion of both 
patients and surgeons was to resume bariatric procedures 
immediately WHO announces the end of the pandemic. 
Patients before surgery preferred to resume bariatric pro-
cedures immediately the number of daily incidents in the 
country begins to decrease. Patients prefered to wait for 
bariatric surgery until the oncological queue has become 
shorter. Surgeons demonstrated a willingness to resume 
bariatric procedures in parallel with oncological surgery 
immediately after the pandemic ends.
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